Abstracts Archive - Page 1527 of 2607 - ACR Meeting Abstracts

Abstract Number: 2096 • 2017 ACR/ARHP Annual Meeting
Nailfold Capillaroscopy Is an Opportunity for Telerheumatology
Jacob R. Stever¹, Nicholas Lebedoff², Tracy M. Frech³, Lesley A. Saketkoo⁴ and Marcus Snow⁵, ¹Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ²Internal Medicine, University of Utah, Salt Lake City, UT, ³Division of Rheumatology, University of Utah, Salt Lake City, UT, ⁴Rheumatology, Tulane University School of Medicine, New Orleans, LA, ⁵Internal Medicine, University of Nebraska, Omaha, NE
Background/Purpose: The 2013 classification criteria for systemic sclerosis (SSc) provide 2 points (towards a 9 point diagnosis) for patients who have abnormal capillaroscopy. In the…
Abstract Number: 2097 • 2017 ACR/ARHP Annual Meeting
Clinical Significance of KL-6 and SP-D As Serum Markers for Interstitial Lung Disease in Patients with Connective Tissue Disease
Kyung-Eun Lee¹, Ji-Hyoun Kang², Dong-Jin Park² and Shin-Seok Lee², ¹Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)
Background/Purpose: To evaluate the association between serum levels of Krebs von den Lungen-6 (KL-6) and surfactant protein-D (SP-D) and the clinical manifestations and severity of…
Abstract Number: 2098 • 2017 ACR/ARHP Annual Meeting
Systemic Treatment for ACUTE Anterior Uveitis ( SYNTHETIC AND BIOLOGIC DISEASE-MODIFYINGANTIRHEUMATIC DRUGS) : A Systematic Literature Review
Alejandro Gómez-Gómez¹, Estibaliz Loza², Maria P Rosario³, Gerard Espinosa⁴, Jose M Ruiz de Morales⁵, Jose M Herreras⁶, Santiago Muñoz⁷ and Miguel Cordero-Coma⁸, ¹Hospital Universitario Infanta Sofía, Madrid, Spain, ²Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, ³Instituto de Salud Musculoesquelética, Madrid, Spain, ⁴Autoimmune Diseases Department. Hospital Clínic de Barcelona, Barcelona, Spain, ⁵Complejo Asistencial Universitario de León, León, Spain, ⁶Ophthalmology, Hospital Universitario, IOBA, Valladolid, Spain, ⁷Rheumatology, Hospital Infanta Sofia, Madrid, Spain, ⁸Ophthalmology, Hospital de León. Spain, León, Spain
Background/Purpose: Acute anterior uveitis (AAU) is the most common form of uveitis. One third of AAU patients may present recurrences, some requiring systemic disease-modifying antirheumatic…
Abstract Number: 2099 • 2017 ACR/ARHP Annual Meeting
Elderly – Onset Sarcoidosis: a Single Center Comparative Study
Senol Kobak¹, Fidan Yildiz², Huseyin Semiz³ and Mehmet Orman⁴, ¹Rheumatology, Istinye University Faculty of Medicine, Istanbul, Turkey, ²Chest Diseases, Medicalpark Hospital, İzmir, Turkey, ³Internal Medicine, Ege University Faculty of Medicine, İzmir, Turkey, ⁴Statistics, Ege University Faculty of Medicine, İzmir, Turkey
Background/Purpose: Sarcoidosis is a chronic granulomatous inflamatory disease characterized with non-caseified granuloma formation. It is rarely affects patients older than 65 years old..The purpose of…
Abstract Number: 2100 • 2017 ACR/ARHP Annual Meeting
An International Consensus Exercise to Develop Candidate Items for Classification Criteria in Relapsing Polychondritis
Marcela A. Ferrada¹, Peter A. Merkel², Keith A. Sikora³, Robert Colbert⁴, Chikashi Terao⁵, Hajime Yoshifuji⁶, Toshiki Nakajima⁷, Aman Sharma⁸, Shirish Sangle⁹, Dax Rumsey¹⁰, Christian Pagnoux¹¹, Larry Young¹², Colleen K. Correll¹³, Fabien Maldonado¹⁴, Robert Lebovics¹⁵, Alexander Gelbard¹⁴, Philip Zapata¹⁶, Allen Clint¹⁷, Otis Rickman¹⁴, Nitin Seam¹⁷, Guillaume Moulis¹⁸, Nathalie Costedoat-Chalumeau¹⁹, Clement J. Michet Jr.²⁰, James D. Katz²¹ and Peter C. Grayson²¹, ¹NIAMS, National Institues of Health, Bethesda, MD, ²Division of Rheumatology, University of Pennsylvania, Philadelphia, MN, ³Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁴National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁵Departments of Genetics and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁶Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, ⁷Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, ⁸Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁹Louise Coote Lupus Unit, Rheumatology and Lupus, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom, ¹⁰Stollery Children's Hospital, Edmonton, AB, Canada, ¹¹Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ¹²Medicine, University of Miami Miller School of Medicine, Miami, FL, ¹³University of Minnesota, Minneapolis, MN, ¹⁴Vanderbilt University Medical Center, Nashville, TN, ¹⁵Mt. Sinai St. Luke's Hospitals, New York, NY, ¹⁶The George Washington University School of Medicine and Health Sciences, Washington, DC, ¹⁷National Institutes of Health, Bethesda, MD, ¹⁸CIC 1436, Toiulouse, France, ¹⁹Service de médecine interne Pôle médecine, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares de l’île de France, Paris, France, ²⁰Division of Rheumatology, Mayo Clinic, Rochester, MN, ²¹National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD
Background/Purpose: There are no validated classification criteria for relapsing polychondritis (RP). Given that some manifestations of RP are organ- or life-threatening, it is imperative that…
Abstract Number: 2101 • 2017 ACR/ARHP Annual Meeting
The Clinical Characteristics of IgG4 Related Disease in China: With 346 Cases Reported
Panpan Zhang¹, Wen Zhang², Jizhi Zhao³, Mu Wang³, Ruie Feng³, Xiaowei Liu³, Xuemei Li³, Yamin Lai³, Xuejun Zeng³, Juhong Shi³, Huijuan Zhu³, Huadan Xue³, Wei Zhang³, Hua Chen⁴, Yunyun Fei³, Linyi Peng³, Xiaofeng Zeng⁵ and Fengchun Zhang³, ¹Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China, ²Rheuamtology, Peking Union Medical College Hospital, Beijing, China, ³Peking Union Medical College Hospital, Beijing, China, ⁴Rheumatology, Peking Union Medical College Hospital, Beijing, China, ⁵Rheumatology, Peking Union Medical College and Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China
Background/Purpose: To study the clinical characteristics of IgG4-RD patients in China Methods: Patients were recruited from a prospective cohort study of IgG4-RD in Peking Union…
Abstract Number: 2102 • 2017 ACR/ARHP Annual Meeting
The Difference between International Criteria for BD (ICBD) and the BD Criteria of International Study Group (ISG) in Our Behcet’s Disease (BD) Patients Who Fulfilled Japanese BD Criteria
Tsuyoshi Kobashigawa, Yuki Nanke, Hisashi Yamanaka and Shigeru Kotake, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: In Japan, we have a criteria for BD since 1988. (International Journal of Tissue Reactions. 1988: 10; 59-65.) In Japanese patients diagnosed according to…
Abstract Number: 2103 • 2017 ACR/ARHP Annual Meeting
Problems in the Diagnosis of Familial Mediterranean Fever in Turkey
Mustafa Erdogan¹, Yesim Ozguler¹, Elif Dincses², Sinem Nihal Esatoglu¹, Gul Guzelant¹, Guzin Karatemiz¹, Serdal Ugurlu³, Gulen Hatemi¹, Huri Ozdogan¹, Hasan Yazici¹ and Emire Seyahi¹, ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey, ³Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
PROBLEMS IN THE DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER (FMF) IN TURKEYBackground/Purpose: The diagnosis of FMF can be missed or delayed even in a country like…
Abstract Number: 2104 • 2017 ACR/ARHP Annual Meeting
Exposure to Fine Particle Air Pollution and Anti-Nuclear Antibodies (ANA) in a Large Population-Based Sample
Sasha Bernatsky¹, Audrey Smargiassi², Lawrence Joseph³, Patrick Belisle³ and Marvin J. Fritzler⁴, ¹Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ²Université de Montreal, Montreal, QC, Canada, ³Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁴Medicine, University of Calgary, Calgary, AB, Canada
Background/Purpose: Fine particle air pollution (PM2.5) has been associated with many conditions including systemic autoimmune rheumatic diseases. Our work has previously suggested an association between…
Abstract Number: 2105 • 2017 ACR/ARHP Annual Meeting
Epidemiology of Interstitial Pneumonia with Autoimmune Features
Robert Mango¹, Ashima Makol², Cynthia S. Crowson³, Jay H. Ryu⁴ and Eric L. Matteson², ¹Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, MN, ²Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁴Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: Interstitial pneumonia with autoimmune features (IPAF) is a subset of interstitial lung disease (ILD) with clinical features suggestive of, but not sufficient for, a…
Abstract Number: 2106 • 2017 ACR/ARHP Annual Meeting
Immune-Related Adverse Events in Cancer Patients Treated with Immune Check Point Inhibitors: A Single Center Experience
Taylor Doberstein¹, Aneet Kaur¹, Elizabeth Field² and Namrata Singh³, ¹Internal Medicine, University of Iowa, Iowa City, IA, ²Iowa City VA, Iowa City, IA, ³Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA
Background/Purpose: The immune checkpoint inhibitors (ICIs) anti-CTLA4 (cytotoxic T-lymphocyte associated protein 4) and anti-PD1 (programmed death cell protein 1) have revolutionized cancer treatment. ICIs interrupt…
Abstract Number: 2107 • 2017 ACR/ARHP Annual Meeting
Therapeutic Response to Prednisone in Relation to Age in Polymyalgia Rheumatica: A Controlled Study
Aline Charpentier¹, Frank Verhoeven^2,3, Maxime Sondag¹, Xavier Guillot⁴, Clément Prati⁵ and Daniel Wendling⁶, ¹rheumatology, CHU de Besançon, Besancon, France, ²EA 4267 FDE, FHU INCREASE, Université de Bourgogne Franche-Comté, Besançon, France, ³Service de Rhumatologie, CHRU J Minjoz, Besançon, France, ⁴EA 4267 FDE, FHU INCREASE, Université de Bourgogne FrancheComté, Besançon, France, ⁵Service de Rhumatologie, CHU J Minjoz, Besancon, France, ⁶Service de Rhumatologie, CHU Jean Minjoz, Besancon, France
Background/Purpose: Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disorder which usually affect patients over 65 years old. Different poor prognostic factors are involved in prednisone…
Abstract Number: 2108 • 2017 ACR/ARHP Annual Meeting
Colchicine Treatment May be Protective Against Ventricular Arrhythmias in FMF Patients
Aslı Gozek Ocal¹, Lutfi Ocal² and Mehmet Engin Tezcan³, ¹Internal Medicine, University of Medical Sciences Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey, ²Cardiology, University of Medical Sciences Kosuyolu Kartal Heart Training and Research Hospital, Istanbul, Turkey, ³Rheumatology, University of Medical Sciences Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey
Background/Purpose: Familial Mediterranean fever (FMF) is an autoinflammatory disease. Colchicine is used in FMF patients for preventing attacks and amyloidosis. There were conflicting reports as…
Abstract Number: 2109 • 2017 ACR/ARHP Annual Meeting
Hyperferritinemic Syndrome in a General Hospital
Ignacio Javier Gandino¹, Florencia Pierini², Jose Maximiliano Martinez P³, Santiago Ruta², Marina Scolnik² and Enrique R Soriano⁴, ¹Reumatologia, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, CABA, Argentina, ³Rheumatology, Internal Medicine Service, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, ⁴Argentina, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background/Purpose: Hyperferritinemia is associated with inflammatory conditions, such as rheumatologic diseases. Objectives: To determine which diseases are associated with hyperferritinemia in a tertiary hospital; to…
Abstract Number: 2110 • 2017 ACR/ARHP Annual Meeting
Blood Group ”a“ Was Increased in FMF Patients and Blood Group ”0“ May be Associated with Colchicine Resistance
Abdulsamet Erden¹, Ezgi Deniz Batu², Berkan Armagan³, Hafize Emine Sonmez⁴, Alper Sari³, Selcan Demir⁴, Emre Bilgin⁵, Esra Fırat⁵, Levent Kilic¹, Yelda Bilginer⁶, Omer Karadag¹, Umut Kalyoncu¹ and Sedat Kiraz¹, ¹Department of Internal Medicine, Divison of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ²Department of Pediatrics, Divison of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey, ³Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁴Department of Pediatrics, Divison of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁵Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁶Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine, ANKARA, Turkey
Background/Purpose: Colchicine is the main therapy for familial Mediterranean fever (FMF). However, about 5-10% of FMF patients are colchicine-resistant (1). The reason for colchicine resistance…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].